UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interests in Operating Subsidiaries
Beginning balance (in shares) at Dec. 31, 2023		99,895,473
Beginning balance at Dec. 31, 2023	$ 589,609	$ 100	$ (98,258)	$ 906,153	$ (239,729)		$ 21,343
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss including noncontrolling interests in subsidiaries	(9,018)				(8,632)		(386)
Other comprehensive income	0
Contributions from noncontrolling interests in subsidiaries	15,250						15,250
Conversion of Series A Redeemable Convertible Preferred Stock to common stock (in shares)		0
Change in ownership percentage in subsidiary	0	$ 0		158			(158)
Stock options exercised (in shares)		61,667
Stock options exercised	223			223
Issuance of common stock for vesting of restricted stock units (in shares)		643,182
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)		(2,802)
Shares withheld related to net share settlement of share-based awards (in shares)		(222,061)
Shares withheld related to net share settlement of share-based awards	(1,068)			(1,068)
Compensation expense for share-based awards	1,749			1,749
Ending balance (in shares) at Jun. 30, 2024		100,375,459
Ending balance at Jun. 30, 2024	596,745	$ 100	(98,258)	907,215	(248,361)		36,049
Beginning balance (in shares) at Mar. 31, 2024		100,021,951
Beginning balance at Mar. 31, 2024	589,604	$ 100	(98,258)	906,337	(239,915)		21,340
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss including noncontrolling interests in subsidiaries	(8,829)				(8,446)		(383)
Other comprehensive income	0
Contributions from noncontrolling interests in subsidiaries	15,250						15,250
Conversion of Series A Redeemable Convertible Preferred Stock to common stock (in shares)		0
Change in ownership percentage in subsidiary	0	$ 0		158			(158)
Stock options exercised (in shares)		61,667
Stock options exercised	223			223
Issuance of common stock for vesting of restricted stock units (in shares)		367,938
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)		(2,802)
Shares withheld related to net share settlement of share-based awards (in shares)		(73,295)
Shares withheld related to net share settlement of share-based awards	(394)			(394)
Compensation expense for share-based awards	891			891
Ending balance (in shares) at Jun. 30, 2024		100,375,459
Ending balance at Jun. 30, 2024	596,745	$ 100	(98,258)	907,215	(248,361)		36,049
Beginning balance (in shares) at Dec. 31, 2024		96,048,999
Beginning balance at Dec. 31, 2024	552,619	$ 96	(118,542)	910,237	(275,786)	$ (1,180)	37,794
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss including noncontrolling interests in subsidiaries	22,091				20,994		1,097
Other comprehensive income	1,525					1,525
Stock options exercised (in shares)		8,333
Stock options exercised	30			30
Issuance of common stock for vesting of restricted stock units (in shares)		521,041
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)		40,777
Shares withheld related to net share settlement of share-based awards (in shares)		(174,157)
Shares withheld related to net share settlement of share-based awards	(670)			(670)
Compensation expense for share-based awards	1,876			1,876
Ending balance (in shares) at Jun. 30, 2025		96,444,993
Ending balance at Jun. 30, 2025	577,471	$ 96	(118,542)	911,473	(254,792)	345	38,891
Beginning balance (in shares) at Mar. 31, 2025		96,171,702
Beginning balance at Mar. 31, 2025	577,260	$ 96	(118,542)	910,688	(251,499)	(518)	37,035
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss including noncontrolling interests in subsidiaries	(1,437)				(3,293)		1,856
Other comprehensive income	863					863
Stock options exercised (in shares)		8,333
Stock options exercised	30			30
Issuance of common stock for vesting of restricted stock units (in shares)		276,412
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)		40,777
Shares withheld related to net share settlement of share-based awards (in shares)		(52,231)
Shares withheld related to net share settlement of share-based awards	(199)			(199)
Compensation expense for share-based awards	954			954
Ending balance (in shares) at Jun. 30, 2025		96,444,993
Ending balance at Jun. 30, 2025	$ 577,471	$ 96	$ (118,542)	$ 911,473	$ (254,792)	$ 345	$ 38,891